Beneficial Effect of Rituximab in the Treatment of Esophageal Cancer–Associated Pauci-Immune Glomerulonephritis

• Heleen Ameye,
• Sabine Fransis,
• Evelyne Lerut,
• Christoph Metalidis,
• Ben Sprangers

Affiliations

Heleen Ameye

Department of Nephrology, University Hospitals Leuven, Leuven, Belgium

Sabine Fransis

Department of Pathology, Ziekenhuis Oost-Limburg Hospital, Genk, Belgium

Evelyne Lerut

Department of Morphology and Molecular Pathology, University Hospitals Leuven, Leuven, Belgium

Christoph Metalidis

Department of Nephrology, Ziekenhuis Oost-Limburg Hospital, Genk, Belgium

Ben Sprangers

Department of Nephrology, University Hospitals Leuven, Leuven, Belgium